agilon health (NYSE:AGL) Upgraded at Sanford C. Bernstein

agilon health (NYSE:AGL - Get Free Report) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage currently has a $8.50 target price on the stock, up from their previous target price of $3.30. Sanford C. Bernstein's price objective indicates a potential upside of 49.52% from the company's current price.

AGL has been the subject of a number of other research reports. Stifel Nicolaus boosted their price objective on shares of agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a research report on Wednesday, February 26th. Needham & Company LLC reiterated a "hold" rating on shares of agilon health in a research report on Friday, March 21st. Citigroup upgraded agilon health from a "sell" rating to a "neutral" rating and boosted their price objective for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Macquarie began coverage on shares of agilon health in a research note on Monday, December 16th. They issued a "neutral" rating and a $3.00 price target on the stock. Finally, Royal Bank of Canada boosted their price objective on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $4.37.

Remove Ads

agilon health Stock Performance

Shares of AGL traded up $0.19 during mid-day trading on Tuesday, hitting $5.69. The stock had a trading volume of 4,167,019 shares, compared to its average volume of 4,742,304. The company has a market cap of $2.34 billion, a PE ratio of -6.05 and a beta of 0.38. The company's fifty day simple moving average is $3.99 and its two-hundred day simple moving average is $3.07. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of AGL. Captrust Financial Advisors boosted its position in shares of agilon health by 10.9% in the 4th quarter. Captrust Financial Advisors now owns 35,485 shares of the company's stock valued at $67,000 after purchasing an additional 3,494 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in agilon health by 2.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company's stock valued at $393,000 after buying an additional 5,107 shares in the last quarter. MetLife Investment Management LLC boosted its holdings in shares of agilon health by 4.0% in the fourth quarter. MetLife Investment Management LLC now owns 174,551 shares of the company's stock worth $332,000 after buying an additional 6,762 shares during the period. Symphony Financial Services Inc. raised its holdings in shares of agilon health by 44.3% during the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company's stock valued at $44,000 after acquiring an additional 7,058 shares during the period. Finally, Signaturefd LLC lifted its position in shares of agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after acquiring an additional 8,467 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.